Company
Fujian Shengdi Pharmaceutical Co., Ltd.
Fujian Shengdi Pharmaceutical Co., Ltd. has 1 drug tracked on RxWires: 1 in Phase 3.
Pipeline
| Drug | Phase | Indication |
|---|---|---|
| HRS-5635 Injection | Phase 3 | Nucleos(t)Ide Analogue-suppressed HBeAg-negative Patients With Chronic Hepatitis B |
Latest
No recent events.
Follow Fujian Shengdi Pharmaceutical Co., Ltd. on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.